{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:14:32Z","timestamp":1790810072084,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.cancergencyto.2009.02.010","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T12:46:56Z","timestamp":1242391616000},"page":"90-96","source":"Crossref","is-referenced-by-count":17,"title":["Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis"],"prefix":"10.1016","volume":"191","author":[{"given":"Doreen","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia-Maria","family":"Monoranu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas U.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Puppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Roggendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.02.010_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1227\/00006123-199510000-00008","article-title":"Intracranial ependymomas of childhood: long-term outcome and prognostic factors","volume":"37","author":"Pollack","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00294447","article-title":"Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases","volume":"82","author":"Figarella-Branger","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cncr.20075","article-title":"The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients","volume":"100","author":"Korshunov","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00000478-200407000-00011","article-title":"Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma","volume":"28","author":"Wolfsberger","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cncr.21608","article-title":"Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas","volume":"106","author":"Kurt","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cncr.20074","article-title":"A multicenter study of the prognosis and treatment of adult brain ependymal tumors","volume":"100","author":"Reni","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/jns.2001.95.1.0009","article-title":"Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers","volume":"95","author":"Tong","year":"2001","journal-title":"J Neurosurg"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00401-001-0479-3","article-title":"Loss of heterozygosity on chromosome 22 in human ependymomas","volume":"103","author":"Huang","year":"2002","journal-title":"Acta Neuropathol (Berlin)"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00401-003-0739-5","article-title":"Human ependymomas reveal frequent deletions on chromosomes 6 and 9","volume":"106","author":"Huang","year":"2003","journal-title":"Acta Neuropathol (Berlin)"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergencyto.2007.12.008","article-title":"Correlation between chromosome 6q25.3 deletion status and survival in pediatric intracranial ependymomas","volume":"182","author":"Monoranu","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9440(10)64061-8","article-title":"Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups","volume":"158","author":"Hirose","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.2001.tb00386.x","article-title":"Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization","volume":"11","author":"Scheil","year":"2001","journal-title":"Brain Pathol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.1086","article-title":"Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH","volume":"197","author":"Jeuken","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)63530-4","article-title":"Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age","volume":"163","author":"Korshunov","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00401-006-0190-5","article-title":"Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival","volume":"113","author":"Lukashova-v Zangen","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib16","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1158\/1078-0432.CCR-03-0721","article-title":"Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients","volume":"10","author":"Lamont","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1593\/neo.05307","article-title":"Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment","volume":"7","author":"Wemmert","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib18","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/cncr.22211","article-title":"Prognostic stratification of patients with anaplastic gliomas according to genetic profile","volume":"107","author":"Dehais","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0360-3016(99)00414-9","article-title":"Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88\/89 and HIT 91","volume":"46","author":"Timmermann","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.radonc.2005.10.016","article-title":"Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92","volume":"77","author":"Timmermann","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib21","series-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<169::AID-GCC8>3.0.CO;2-M","article-title":"Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32","volume":"27","author":"Nishiwaki","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.135.4.1071","article-title":"Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex","volume":"135","author":"Hecht","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1388-1981(02)00150-6","article-title":"Multiple astrocyte responses to lysophosphatidic acids","volume":"1582","author":"Steiner","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib25","first-page":"335","article-title":"Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma","volume":"13","author":"Beetz","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib26","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","article-title":"Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1","volume":"17","author":"Saitoh","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1010623119469","article-title":"Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization","volume":"52","author":"Sprenger","year":"2001","journal-title":"J Neurooncol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-4608(01)00611-2","article-title":"Genome-wide survey for chromosomal imbalances in ganglioglioma using comparative genomic hybridization","volume":"134","author":"Yin","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/sj.onc.1209851","article-title":"Frequent loss of chromosome 9, homozygous CDKN2A\/p14(ARF)\/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas","volume":"26","author":"Weber","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/gcc.20635","article-title":"Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma","volume":"48","author":"Milde","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-4608(00)00265-X","article-title":"Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas","volume":"122","author":"Zheng","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-4608(02)00516-2","article-title":"Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas","volume":"136","author":"Grill","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccr.2005.09.001","article-title":"Radial glia cells are candidate stem cells of ependymoma","volume":"8","author":"Taylor","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib34","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1200\/JCO.2006.06.3701","article-title":"Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics","volume":"24","author":"Modena","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2009.02.010_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/B:NEON.0000013493.31107.20","article-title":"Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox?","volume":"66","author":"Gilhuis","year":"2004","journal-title":"J Neurooncol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T11:24:01Z","timestamp":1545218641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0165460809001046"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.02.010","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}